Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/04/1991 | EP0459829A1 Pharmacologically active CNS compounds |
12/04/1991 | EP0459819A2 Pharmacologically active CNS compound |
12/04/1991 | EP0459748A2 Thien-2-yl methylurea derivatives as leukotriene inhibitors |
12/04/1991 | EP0459730A2 Anti-tumour compounds |
12/04/1991 | EP0459702A1 Azole Derivatives |
12/04/1991 | EP0459666A2 Medicaments against impotence |
12/04/1991 | EP0459632A1 Composition and method for controlling cholesterol |
12/04/1991 | EP0459568A2 Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use |
12/04/1991 | EP0459561A2 Dioxo-tetrahydroquinoline derivatives |
12/04/1991 | EP0459505A1 Imidazonaphthyridine derivatives |
12/04/1991 | EP0459462A1 Xylobiose containing composition |
12/04/1991 | EP0459453A2 Use of pravastatin for preventing onset of restenosis after angioplasty |
12/04/1991 | EP0459449A1 Furano[2,3-F]isoindoles as aldose reductase inhibitors |
12/04/1991 | EP0459432A1 Treatment of diseases with paf-acether antagonists and procedure for determining their efficacy |
12/04/1991 | EP0459381A2 Process for the preparation of 10-(2-propynyl)ester-4-ene-3,17-dione |
12/04/1991 | EP0459377A2 Use of E1 prostaglandin to cure male erectile inpotence |
12/04/1991 | EP0459367A1 Method for preparing an antitumor dextran |
12/04/1991 | EP0459318A2 Method for preventing onset of restenosis after angioplasty employing an ACE inhibitor |
12/04/1991 | EP0459298A2 Use of substituted beta-hydroxyethylamines as potent inhibitors of a fungal exoenzyme |
12/04/1991 | EP0459256A1 Oxazolidinones with CNS-depressant activity |
12/04/1991 | EP0459200A2 Chlorin derivatives |
12/04/1991 | EP0459176A2 Oligophosphates with antiviral activity |
12/04/1991 | EP0459148A2 Dry eye treatment composition |
12/04/1991 | EP0459136A1 Benzimidazole derivatives, their production and use |
12/04/1991 | EP0459108A2 Rice dextrin oral rehydration solution |
12/04/1991 | EP0458965A1 Process for the preparation of vinyl ethers. |
12/04/1991 | EP0458924A1 Pharmaceutical preparations |
12/04/1991 | EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
12/04/1991 | EP0458901A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
12/04/1991 | EP0458886A1 Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation. |
12/04/1991 | EP0458823A1 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines. |
12/04/1991 | EP0308456B1 Compositon for the treatment of the epiderm |
12/04/1991 | CN1056693A Pharmachutical compounds |
12/04/1991 | CN1056691A Sulfonyl compounds and process for preparing same |
12/04/1991 | CN1056690A Pyrrolopyridazine compounds |
12/04/1991 | CN1056688A Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrine-derivatives |
12/04/1991 | CN1056686A Improved process for preparation of substituted indolone derivatives |
12/04/1991 | CN1056685A Indole derivatives and process for production thereof |
12/04/1991 | CN1056684A Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides pharmaceuticals containing these compounds and their use |
12/04/1991 | CN1056683A Oxalylamino acid derivatives, processes for their preparation and their use as medicaments for inhibiting proline hydroxylase |
12/04/1991 | CN1056680A Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
12/04/1991 | CN1014993B 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and their use as antidepressants |
12/04/1991 | CN1014992B Quinazolidione and pyridopyrimidine dione and preparing method |
12/04/1991 | CN1014990B 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith |
12/03/1991 | US5070190 Substituted n-glycosylamides, process for their preparation, and their use as medicaments |
12/03/1991 | US5070139 2,4-disubstituted 1,3-dioxolanes |
12/03/1991 | US5070108 Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal |
12/03/1991 | US5070107 Aliphatic straight-chain alcohols having 27 to 32 carbons in t he chain |
12/03/1991 | US5070106 Compounds active on the cardiovascular system |
12/03/1991 | US5070104 Methods of chelating metal and novel compositions therefor |
12/03/1991 | US5070103 Naphthalene derivatives and composition and methods of use, and aldehyde intermediates |
12/03/1991 | US5070102 Medicaments for the treatment of cerebral apoplexy |
12/03/1991 | US5070101 Method and pharmaceutical composition for the treatment of schizophrenia |
12/03/1991 | US5070096 Quinolinoxy phenylsulphonamides |
12/03/1991 | US5070094 N-benzyltropaneamides |
12/03/1991 | US5070092 Pyrroloindole derivatives related to dc-88a compound |
12/03/1991 | US5070091 Substituted 1,2,4-triazinediones useful against protozoa in insects |
12/03/1991 | US5070087 Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents |
12/03/1991 | US5070085 Compositions and methods for administering therapeutically active compounds |
12/03/1991 | US5070084 Adrenergic blocking agent |
12/03/1991 | US5070080 Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form |
12/03/1991 | US5070079 Pharmaceutical compositions containing cytidine monophosphate of 5-acetamido-3-, 5-d-deoxy-d-glycero-d-galacto-nonulosamic acid |
12/03/1991 | US5070078 Adenovirus |
12/03/1991 | US5070010 Method for determining anti-viral transactivating activity |
12/03/1991 | US5069911 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions |
12/03/1991 | US5069910 Dispersible cimetidine tablets |
12/03/1991 | US5069909 Transdermal administration of buprenorphine |
12/03/1991 | US5069905 Method and compositions comprising a vitamin d derivatives for the local treatment of bone fractures |
12/03/1991 | US5069904 Alzheimer's disease |
12/03/1991 | US5069898 Hair enrichment composition and method of use |
12/03/1991 | US5069895 Adenosine agonists and antagonists |
12/03/1991 | CA1292749C Platinum complexes |
12/03/1991 | CA1292747C Aralykyl (arylethynyl) aralkyl amines and their use as vasodilators and antihypertensives |
12/03/1991 | CA1292745C Preparation of substituted 8-thiotetrahydroquinoline derivatives |
12/03/1991 | CA1292744C 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments |
12/03/1991 | CA1292742C Octahydro-oxazolo (4,5-g)quinolines |
12/03/1991 | CA1292741C Benzimidazolylpyridazinones |
12/03/1991 | CA1292740C Benzothiopyrano(4,3-c)pyridazine compounds, methods for preparing said compounds and uses of said compounds |
12/03/1991 | CA1292739C Heteroaromatic acetylenes useful as antihypertensive agents |
12/03/1991 | CA1292698C Contraceptive composition |
12/03/1991 | CA1292696C Vaginal pharmaceutical composition having sperm motility enhancing activity |
12/03/1991 | CA1292695C Anaerobe-selective antibacterial compositions and methods |
12/03/1991 | CA1292694C Inhibition of interleukin-1 by monocytes and/or macrophages |
12/03/1991 | CA1292693C Pharmaceutical preparation containing omeprazole |
12/03/1991 | CA1292684C Diuretic composition containing furosemide |
12/02/1991 | WO1991018899A1 3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them |
12/02/1991 | WO1991018866A2 1,4-diamino-2,3-dihydroxybutanes |
12/02/1991 | WO1991018602A1 (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL |
12/02/1991 | CA2084087A1 1,4-diamino 2,3-dihydroxy butanes |
12/02/1991 | CA2043671A1 Pharmacologically active cns compounds |
12/02/1991 | CA2043642A1 Pharmacologically active cns compounds |
12/02/1991 | CA2043640A1 Pharmacologically active cns compounds |
12/02/1991 | CA2043341A1 Pharmaceutical compounds |
12/01/1991 | WO1991019475A1 Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene d¿4? |
12/01/1991 | WO1991018607A1 Febarbamate for the treatment of cranial nervous disorders and encephalic circulation and metabolism disorders |
12/01/1991 | WO1991018595A1 An antiviral composition |
12/01/1991 | CA2083822A1 Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene d4 |
12/01/1991 | CA2063736A1 Febarbamate for the treatment of cranial nervous disorders and encephalic circulation and metabolism disorders |
12/01/1991 | CA2043573A1 Compounds for use in slowing hair loss and for inducing and stimulating hair growth containing derivatives of alkyl-2-amino-4-(or dialkyl-2,4) pyrimidine-oxyde-3 and new compoundsderived from alkyl-2-amino-4-pyrimidine-oxyde-3 |
12/01/1991 | CA2043468A1 Sulfur-containing heterocyclic compounds |